Galecto (NASDAQ:GLTO) CEO Hans Schambye Sells 700 Shares
Galecto, Inc. (NASDAQ:GLTO - Get Free Report) CEO Hans Schambye sold 700 shares of the business's stock in a transaction dated Friday, January 2nd. The stock was sold at an average price of $21.38...
MarketBeat·13d ago
More News
Is the Market Bullish or Bearish on Galecto Inc?
read more...
Benzinga·19d ago
Galecto (NASDAQ:GLTO) Shares Down 13.3% - Time to Sell?
Galecto (NASDAQ:GLTO) Stock Price Down 13.3% - Here's Why...
MarketBeat·22d ago
Small Cap Stocks To Watch Today - November 11th
Spring Valley Acquisition, enGene, Canadian Solar, Galecto, RealReal, Daily Journal Corp. (S.C.), and Navitas Semiconductor are the seven Small Cap stocks to watch today, according to MarketBeat's...
MarketBeat·2mo ago
Small Cap Stocks To Research - November 10th
Spring Valley Acquisition, Galecto, Movano, Papa John's International, Strive, Inflection Point Acquisition Corp. II, and Direxion Daily PLTR Bull 2X Shares are the seven Small Cap stocks to watch...
MarketBeat·2mo ago
Galecto Stock Surges Premarket After Damora Acquisition — Retail Bulls Predict Another Massive Rally
Galecto announced the acquisition of Damora Therapeutics and a $285 million private raise backed by major biotech investors, including Viking Global, RA Capital, and a16z Bio + Health.
Stocktwits·2mo ago
GLTO Stock Rises A Whopping 632% Pre-Market, But Retail Investors Remain Cautious
Galecto is focused on developing treatments for oncological and liver diseases.